chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Pruritus, Rash, Rash pruritic
Clinical narrative: 6 dots on her knees; rash on her hands and knees that itched like crazy; Itching; Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (6 dots on her knees), RASH PRURITIC (rash on her hands and knees that itched like crazy), PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Seizures. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LEVETIRACETAM (KEPPRA [LEVETIRACETAM]), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), VITAMINS NOS, ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D3, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) and MAGNESIUM for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced RASH PRURITIC (rash on her hands and knees that itched like crazy), PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash). On an unknown date, the patient experienced ERYTHEMA (6 dots on her knees). The patient was treated with STEROIDS on 09-Mar-2021 for Adverse event, at a dose of 7 days. On 03-Mar-2021, PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash) had resolved. On 04-Mar-2021, RASH PRURITIC (rash on her hands and knees that itched like crazy) had resolved. At the time of the report, ERYTHEMA (6 dots on her knees) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97.6 degree Celsius normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received her first dose on 16-Feb-2021 in her left arm and reported that ten days later she developed a rash on her hands and knees that itched like crazy and it lasted for six days. She also had six dots on her knees and the redness stayed until the date got closer to her second dose.   She was prescribed prednisone (as treatment) but stopped taking in time before second dose.  The patient reported events to be related to Moderna Vaccine.   This case was linked to MOD-2021-101720 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated patient details, suspect product details, concomitant medications, treatment medications and event details.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: 6 dots on her knees; rash on her hands and knees that itched like crazy; Itching; Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (6 dots on her knees), RASH PRURITIC (rash on her hands and knees that itched like crazy), PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Seizures. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LEVETIRACETAM (KEPPRA [LEVETIRACETAM]), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), VITAMINS NOS, ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D3, CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) and MAGNESIUM for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced RASH PRURITIC (rash on her hands and knees that itched like crazy), PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash). On an unknown date, the patient experienced ERYTHEMA (6 dots on her knees). The patient was treated with STEROIDS on 09-Mar-2021 for Adverse event, at a dose of 7 days. On 03-Mar-2021, PRURITUS (Itching), URTICARIA (Hives) and RASH (Rash) had resolved. On 04-Mar-2021, RASH PRURITIC (rash on her hands and knees that itched like crazy) had resolved. At the time of the report, ERYTHEMA (6 dots on her knees) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97.6 degree Celsius normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received her first dose on 16-Feb-2021 in her left arm and reported that ten days later she developed a rash on her hands and knees that itched like crazy and it lasted for six days. She also had six dots on her knees and the redness stayed until the date got closer to her second dose.   She was prescribed prednisone (as treatment) but stopped taking in time before second dose.  The patient reported events to be related to Moderna Vaccine.   This case was linked to MOD-2021-101720 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated patient details, suspect product details, concomitant medications, treatment medications and event details.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dry mouth, Dysgeusia, Fatigue
Clinical narrative: rash on right arm near the spot where the vaccine was given; Tired; right arm around where the vaccine was given began to ache; Chills; after 30 hours later he had problem of aches; Pain in elbow/Aching in elbow, wrist pain; Dry feeling in mouth; Pain in middle finger of left arm, Pain in wrist; metallic like taste; warm feeling in arms and hands; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands) and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Food allergy. Concomitant products included SIMVASTATIN for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, SIMVASTATIN (ZOCOR), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]) and TAMSULOSIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain). On 18-Mar-2021, the patient experienced FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given). On 18-Mar-2021, DRY MOUTH (Dry feeling in mouth), DYSGEUSIA (metallic like taste) and FEELING HOT (warm feeling in arms and hands) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain) had resolved and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given), FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication information was reported.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Allergy, Concomitant and new Events are updated.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Myalgia, Pain in extremity, Vaccination site pain, Vaccination site rash
Clinical narrative: rash on right arm near the spot where the vaccine was given; Tired; right arm around where the vaccine was given began to ache; Chills; after 30 hours later he had problem of aches; Pain in elbow/Aching in elbow, wrist pain; Dry feeling in mouth; Pain in middle finger of left arm, Pain in wrist; metallic like taste; warm feeling in arms and hands; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands) and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Food allergy. Concomitant products included SIMVASTATIN for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, SIMVASTATIN (ZOCOR), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]) and TAMSULOSIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain). On 18-Mar-2021, the patient experienced FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given). On 18-Mar-2021, DRY MOUTH (Dry feeling in mouth), DYSGEUSIA (metallic like taste) and FEELING HOT (warm feeling in arms and hands) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain) had resolved and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given), FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication information was reported.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Allergy, Concomitant and new Events are updated.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: Menstrual bleeding (off cycle); This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (Menstrual bleeding (off cycle)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 027B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced MENSTRUAL DISORDER (Menstrual bleeding (off cycle)). At the time of the report, MENSTRUAL DISORDER (Menstrual bleeding (off cycle)) had not resolved. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Headache, Lip blister, Lip swelling, Myalgia
Clinical narrative: body aches; head hurt like hell; swollen lips; lip blisters; face was swollen; eyes were swollen shut; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lips), LIP BLISTER (lip blisters), SWELLING FACE (face was swollen), EYE SWELLING (eyes were swollen shut) and MYALGIA (body aches) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003621A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergic reaction NOS. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and EPINEPHRINE for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced LIP SWELLING (swollen lips) and LIP BLISTER (lip blisters). 29-Apr-2021, the patient experienced SWELLING FACE (face was swollen) and EYE SWELLING (eyes were swollen shut). On an unknown date, the patient experienced MYALGIA (body aches) and HEADACHE (head hurt like hell). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Myalgia and Headache, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Apr-2021, LIP SWELLING (swollen lips), LIP BLISTER (lip blisters), SWELLING FACE (face was swollen) and EYE SWELLING (eyes were swollen shut) had resolved. At the time of the report, MYALGIA (body aches) and HEADACHE (head hurt like hell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated that she had allergic reactions in the past so she took Claritin D before receiving the shot.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: body aches; head hurt like hell; swollen lips; lip blisters; face was swollen; eyes were swollen shut; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lips), LIP BLISTER (lip blisters), SWELLING FACE (face was swollen), EYE SWELLING (eyes were swollen shut) and MYALGIA (body aches) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003621A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergic reaction NOS. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and EPINEPHRINE for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced LIP SWELLING (swollen lips) and LIP BLISTER (lip blisters). 29-Apr-2021, the patient experienced SWELLING FACE (face was swollen) and EYE SWELLING (eyes were swollen shut). On an unknown date, the patient experienced MYALGIA (body aches) and HEADACHE (head hurt like hell). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Myalgia and Headache, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 30-Apr-2021, LIP SWELLING (swollen lips), LIP BLISTER (lip blisters), SWELLING FACE (face was swollen) and EYE SWELLING (eyes were swollen shut) had resolved. At the time of the report, MYALGIA (body aches) and HEADACHE (head hurt like hell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated that she had allergic reactions in the past so she took Claritin D before receiving the shot.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: felt a lot of liquid falling out of her arm while being vaccinated; felt a lot of liquid falling out of her arm while being vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated). At the time of the report, UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: Received Hep-B Vaccine 27 Days after First dose of Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Received Hep-B Vaccine 27 Days after First dose of Moderna COVID-19 Vaccine) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: HEP-B-VAX on 03-May-2021.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Received Hep-B Vaccine 27 Days after First dose of Moderna COVID-19 Vaccine). On 03-May-2021, INTENTIONAL PRODUCT USE ISSUE (Received Hep-B Vaccine 27 Days after First dose of Moderna COVID-19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Dysgeusia, Muscle tightness, Muscle twitching, Pain
Clinical narrative: dry mouth; metallic taste in mouth and still having that metallic taste but it went away for several days and come back; On same day but few hours later he felt tightness around the lips; stretched near to cheek area; Twitching in lower jaw specially right under the base of his tounge; Pain; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back), MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Reaction to preservatives (Allergy to Phosphate , food preservative). Concomitant products included SIMVASTATIN (ZOCOR) for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Prostate infection.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (Pain). On 14-Apr-2021, the patient experienced DRY MOUTH (dry mouth), DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back), MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Dry mouth, Taste metallic and Twitching, at a dose of 1 dosage form. On 18-Mar-2021, PAIN (Pain) had resolved. At the time of the report, DRY MOUTH (dry mouth) and DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back) had resolved and MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge) was resolving. Unknown          No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-up received on 09-JUN-2021.Patients medical information was updated.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Skin tightness
Clinical narrative: dry mouth; metallic taste in mouth and still having that metallic taste but it went away for several days and come back; On same day but few hours later he felt tightness around the lips; stretched near to cheek area; Twitching in lower jaw specially right under the base of his tounge; Pain; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back), MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Reaction to preservatives (Allergy to Phosphate , food preservative). Concomitant products included SIMVASTATIN (ZOCOR) for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Prostate infection.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (Pain). On 14-Apr-2021, the patient experienced DRY MOUTH (dry mouth), DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back), MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Dry mouth, Taste metallic and Twitching, at a dose of 1 dosage form. On 18-Mar-2021, PAIN (Pain) had resolved. At the time of the report, DRY MOUTH (dry mouth) and DYSGEUSIA (metallic taste in mouth and still having that metallic taste but it went away for several days and come back) had resolved and MUSCLE TIGHTNESS (On same day but few hours later he felt tightness around the lips), SKIN TIGHTNESS (stretched near to cheek area) and MUSCLE TWITCHING (Twitching in lower jaw specially right under the base of his tounge) was resolving. Unknown          No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-up received on 09-JUN-2021.Patients medical information was updated.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Little left arm pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Little left arm pain at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced INJECTION SITE PAIN (Little left arm pain at injection site). At the time of the report, INJECTION SITE PAIN (Little left arm pain at injection site) outcome was unknown. Not Provided          Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-037346 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling, Swelling face, Vaccination site rash
Clinical narrative: Swollen face; Swollen around eyes; Swollen around lips; Rash on arm of injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Swollen face), EYE SWELLING (Swollen around eyes), LIP SWELLING (Swollen around lips) and VACCINATION SITE RASH (Rash on arm of injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Swollen face), EYE SWELLING (Swollen around eyes), LIP SWELLING (Swollen around lips) and VACCINATION SITE RASH (Rash on arm of injection site). At the time of the report, SWELLING FACE (Swollen face), EYE SWELLING (Swollen around eyes), LIP SWELLING (Swollen around lips) and VACCINATION SITE RASH (Rash on arm of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling of body temperature change, Headache, Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph nodes under my left arm; pounding headache at night; Severe joint pain; arm was sore; Itchy; Felt really hot and cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), LYMPHADENOPATHY (swollen lymph nodes under my left arm) and HEADACHE (pounding headache at night) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), HEADACHE (pounding headache at night) and ARTHRALGIA (Severe joint pain). On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes under my left arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 30-Apr-2021, PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), HEADACHE (pounding headache at night) and ARTHRALGIA (Severe joint pain) had resolved. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes under my left arm) had resolved.            concomitant medication was not reported.   This case was linked to MOD-2021-101702 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Significant follow-up received on 22-07-21 Additional event  of some swelling of lymph nodes under arm and outcome has been updated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: swollen lymph nodes under my left arm; pounding headache at night; Severe joint pain; arm was sore; Itchy; Felt really hot and cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), LYMPHADENOPATHY (swollen lymph nodes under my left arm) and HEADACHE (pounding headache at night) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), HEADACHE (pounding headache at night) and ARTHRALGIA (Severe joint pain). On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes under my left arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 30-Apr-2021, PAIN IN EXTREMITY (arm was sore), PRURITUS (Itchy), FEELING OF BODY TEMPERATURE CHANGE (Felt really hot and cold), HEADACHE (pounding headache at night) and ARTHRALGIA (Severe joint pain) had resolved. At the time of the report, LYMPHADENOPATHY (swollen lymph nodes under my left arm) had resolved.            concomitant medication was not reported.   This case was linked to MOD-2021-101702 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Significant follow-up received on 22-07-21 Additional event  of some swelling of lymph nodes under arm and outcome has been updated.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; fatigue for about a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days) outcome was unknown.            No treatment and concomitant medication information was reported.   This case was linked to MOD-2021-097892.   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Follow up received on 30-May-2021: includes no new information (NNI).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Incomplete course of vaccination, Underdose
Clinical narrative: second dose wasn't fully administered; Part of the vaccine spilled out down her arm; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (second dose wasn't fully administered) and INCOMPLETE COURSE OF VACCINATION (Part of the vaccine spilled out down her arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced UNDERDOSE (second dose wasn't fully administered). 03-May-2021, the patient experienced INCOMPLETE COURSE OF VACCINATION (Part of the vaccine spilled out down her arm). On 03-May-2021, UNDERDOSE (second dose wasn't fully administered) and INCOMPLETE COURSE OF VACCINATION (Part of the vaccine spilled out down her arm) had resolved. Not provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling, Tenderness
Clinical narrative: Tenderness in armpit; Swelling in his armpit in the arm of the injection site; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of every 4 to 6 hours and NAPROXEN SODIUM (ALEVE) for Muscle pain, at an unspecified dose and frequency. At the time of the report, TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-101705 (E2B Linked Report).; Sender's Comments:  MOD-2021-101705:Dose 1
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site reaction
Clinical narrative: I have metal detectors going off and magnets sticking to me where shot was giving; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (I have metal detectors going off and magnets sticking to me where shot was giving) and PYREXIA (fever) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031821A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for Thyroid disorder.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced VACCINATION SITE REACTION (I have metal detectors going off and magnets sticking to me where shot was giving). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (I have metal detectors going off and magnets sticking to me where shot was giving) and PYREXIA (fever) outcome was unknown.            Patient's temperature at the time of report was 99.7  Concomitant medicine include levothyroxine Treatment medicine include Tylenol   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Followup received on 21-JUL-2021, and event was added
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: beyond 36 days from receiving first dose; contracted COVID-19/diagnosed with COVID-19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (contracted COVID-19/diagnosed with COVID-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (beyond 36 days from receiving first dose) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LOVASTATIN, PROPRANOLOL and MONOCLONAL ANTIBODIES for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced COVID-19 (contracted COVID-19/diagnosed with COVID-19). On 03-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (beyond 36 days from receiving first dose). On 03-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (beyond 36 days from receiving first dose) had resolved. At the time of the report, COVID-19 (contracted COVID-19/diagnosed with COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Bad pain left shoulder) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (Bad pain left shoulder). At the time of the report, ARTHRALGIA (Bad pain left shoulder) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Neck pain, Vaccination site discolouration
Clinical narrative: arm had yellow-green spot and half at the injection site; aching at C4 and L5/stabbing pain; aching at C4 and L5/stabbing pain and her shoulders were also hurting; shoulders were also hurting; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE DISCOLOURATION (arm had yellow-green spot and half at the injection site), BACK PAIN (aching at C4 and L5/stabbing pain), NECK PAIN (aching at C4 and L5/stabbing pain and her shoulders were also hurting) and ARTHRALGIA (shoulders were also hurting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048-A21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis, Postmenopausal symptoms, Hysterectomy and Fusion of vertebra (fusion of C4 and L5). Concurrent medical conditions included Acid reflux (esophageal), Blood pressure fluctuation and Thyroid disorder NOS. Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), LISINOPRIL and CARVEDILOL for Blood pressure management, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, PARACETAMOL (TYLENOL), GUAIFENESIN (MUCINEX), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (arm had yellow-green spot and half at the injection site), BACK PAIN (aching at C4 and L5/stabbing pain), NECK PAIN (aching at C4 and L5/stabbing pain and her shoulders were also hurting) and ARTHRALGIA (shoulders were also hurting). On 15-Mar-2021, BACK PAIN (aching at C4 and L5/stabbing pain), NECK PAIN (aching at C4 and L5/stabbing pain and her shoulders were also hurting) and ARTHRALGIA (shoulders were also hurting) had resolved. On 23-Mar-2021, VACCINATION SITE DISCOLOURATION (arm had yellow-green spot and half at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not reported.   This case was linked to MOD-2021-101745 (Patient Link).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: pain at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication a Cream (Unknown drug).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy
Clinical narrative: Developed a lymph node size of 2 cue ball's in armpit of injected arm; fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Developed a lymph node size of 2 cue ball's in armpit of injected arm), FATIGUE (fatigue) and HEADACHE (Headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included METFORMIN and ATORVASTATIN for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced LYMPHADENOPATHY (Developed a lymph node size of 2 cue ball's in armpit of injected arm), FATIGUE (fatigue) and HEADACHE (Headache). At the time of the report, LYMPHADENOPATHY (Developed a lymph node size of 2 cue ball's in armpit of injected arm), FATIGUE (fatigue) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: The first dose made the patient wheezy; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (The first dose made the patient wheezy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure abnormal, Blood cholesterol abnormal and Thyroid disorder NOS.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WHEEZING (The first dose made the patient wheezy). At the time of the report, WHEEZING (The first dose made the patient wheezy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient took concomitantly unspecified diabetes medication, blood pressure medication, cholesterol medication, and thyroid medication. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-101739 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Vaccine start date and batch/lot # was provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Pruritus, Rash
Clinical narrative: Both her arms really itchy; allergic reaction; has red bumps like a rash on her arms; has red bumps like a rash on her arms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Both her arms really itchy), HYPERSENSITIVITY (allergic reaction), ERYTHEMA (has red bumps like a rash on her arms) and RASH (has red bumps like a rash on her arms) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced PRURITUS (Both her arms really itchy), HYPERSENSITIVITY (allergic reaction), ERYTHEMA (has red bumps like a rash on her arms) and RASH (has red bumps like a rash on her arms). At the time of the report, PRURITUS (Both her arms really itchy), HYPERSENSITIVITY (allergic reaction), ERYTHEMA (has red bumps like a rash on her arms) and RASH (has red bumps like a rash on her arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. no treatment information provided by the reporter